Glutathione Transferase P1–1 Expression in Human Melanoma Metastases: Correlation to N-RAS mutations and expression

References

• Mannervik B, Ålin P, Guthenberg C, et al. Identification of three classes of cytosolic glutathione transferase common to several mammalian species: correlation between structural data and enzymatic properties. Proc Natl Acad Sci USA 1985; 82: 7202–6
   PubMed Web of Science ®Google Scholar
• Mannervik B. The isoenzymes of glutathione transferase. Adv Enzymol Relat Areas Mol Biol 1985; 57: 357–417
   PubMedGoogle Scholar
• Mannervik B, Castro V M, Danielson U H, Tahir M K, Hansson J, Ringborg U. Expression of class Pi glutathione transferase in human malignant melanoma cells. Carcinogenesis 1987; 8: 1929–32
   PubMed Web of Science ®Google Scholar
• Campell A H, Corrigal A V, Guy A, Kirsch R E. Immunohistological localization of Alpha, Mu and Pi class glutathione S‐transferases in human tissues. Cancer 1991; 67: 1608–13
   PubMedGoogle Scholar
• Tew K D. Glutathione associated enzymed in anticancer drug resistance. Cancer Res 1994; 54: 4313–20
   PubMed Web of Science ®Google Scholar
• Cowell G I, Dixon K H, Pemble E S, Ketter B, Taylor J B. The structure of the human glutathione S‐transferase pi gene. Biochem J 1988; 255: 79–83
   PubMed Web of Science ®Google Scholar
• Moffat G J, Mc Laren A W, Wolf C R. Involvement of Jun and Fos proteins in regulating transcriptional activation of the human pi class glutathione S—transferase gene in multidrugresistant MCF 7 breast cancer cells. J Biol Chem 1994; 269: 16397–402
   PubMed Web of Science ®Google Scholar
• Egan S E, Weinberg R A. The pathway to signal achievement. Nature 1993; 365: 781–3
   PubMed Web of Science ®Google Scholar
• Bos J L. Ras oncogenes in human cancer: a review. Cancer Res 1989; 49: 4682–9
   PubMed Web of Science ®Google Scholar
• Mangues R, Seidman I, Gordon J W, Pellicer A. Overexpression of the N‐ras proto‐oncogene, not somatic mutational activation, associated with malignant tumors in transgenic mice. Oncogene 1992; 7: 2073–6
   PubMedGoogle Scholar
• Slamon D J, de Kernion B, Verma I M, Cline M J. Expression of cellular oncogenes in human malignancies. Science 1984; 224: 256–62
   PubMed Web of Science ®Google Scholar
• Albino A P, Nanus D M, Mentle I R, et al. Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype. Oncogene 1989; 4: 1363–74
   PubMed Web of Science ®Google Scholar
• Van't Veer J L, Burgering B M T, Versteeg R, et al. N‐ras mutations in human cutaneous melanoma from sun‐exposed body sites. Mol Cell Biol 1989; 9: 3114–6
   PubMedGoogle Scholar
• Ball N J, Yohn J J, Morelli J G, Norris D A, Golitz L E, Hoeffler P J. Ras mutations in human melanoma: a marker of malignant progression. J Invest Dermatol 1994; 102: 285–90
   PubMed Web of Science ®Google Scholar
• Platz A, Ringborg U, Minsson Brahme E, Lagerlof B. Melanoma metastases from patients with hereditary cutaneous malignant melanoma contain a high frequency of Nras activating mutations. Melanoma Res 1994; 4: 169–77
   PubMed Web of Science ®Google Scholar
• Platz A, Ringborg U, Grafström E, Höög A, Lagerlöf B. Immunohistochemical analysis of the N‐ras p21 and the p53 proteins in naevi, primary tumors and metastases of human cutaneous malignant melanoma: increased immunopositivity in hereditary melanoma. Melanoma Res 1995; 5: 101–6
   PubMedGoogle Scholar
• Shukla V K, Hughes D C, Hughes L E, Mc Cormick F, Padua R A. Ras‐mutations in human melanocytic lesions: K‐ras activations a frequent and early event in melanoma development. Oncogene Res 1989; 5: 121–7
   PubMedGoogle Scholar
• Burt K R, Garfield S, Johnson K, Thorgeirsson S S. Transformation of rat liver epithelial cells with v‐H‐ras or v‐raf causes expression of MDR‐1, glutathione S‐transferase P and increased resistance to cytotoxic chemicals. Carcinogenesis 1988; 9: 2329–32
   PubMed Web of Science ®Google Scholar
• Power C, Sinha S, Webber C, Mansson M M, Neal G E. Transformation related expression of glutathione S‐trans‐ferase P in rat liver cells. Carcinogenesis 1987; 8: 797–801
   PubMed Web of Science ®Google Scholar
• Li Y, Seyama T, Godwin A K, Winoukur T S, Lebovitz R M, Lieberman M W. MTrasT24, a metallothionein‐ras fusion gene, modulates expression in cultured rat liver cells of two genes associated with in vivo liver cancer. Proc Natl Acad Sci USA 1988; 85: 344–8
   PubMed Web of Science ®Google Scholar
• Dixon K H, Cowell I G, Xia C L, Pemble S E, Ketterer B, Taylor J B. Control of expression of the human glutathione S‐transferase pi gene differs from its rat orthologue. Biochem Biophys Res Commun 1989; 163: 815–22
   PubMed Web of Science ®Google Scholar
• Xia C, Taylor I B, Spencer S R, Ketterer B. The human glutathione S‐transferase P1–l gene: modulation of expression by retinoic acid and insulin. Biochim J 1993; 292: 845–85
   PubMed Web of Science ®Google Scholar
• Morimura S, Suzuki T, Hocki S ‐I, et al. Trans‐activation of glutathione transferase P gene during chemical hepatocarcinogenesis of the rat. Proc Natl Acad Sci USA 1993; 90: 2065–8
   PubMed Web of Science ®Google Scholar
• Hao X Y, Castro V M, Bergh J, Sundström B, Mannervik B. Isoenzyme‐specific quantitative immunoassays for cytosolic glutathione transferase and measurement of the enzymes on blood plasma from cancer patients and in tumor cell lines. Biochim Biophys Acta 1994; 1225: 223–30
   PubMed Web of Science ®Google Scholar
• Thor A, Horan Hand P, Wunderlich D, Caruso A, Muraro R, Schlom J. Monoclonal antibodies define differential ras gene expression in malignant and benign colonic disease. Nature 1984; 311: 562–5
   PubMed Web of Science ®Google Scholar
• Horan Hand P, Thor A, Wunderlich D, Muraro R, Caruso A, Schlom J. Monoclonal antibodies of predefined specificity detect activated ras gene expression in human mammary and colon carcinoma. Proc Natl Acad Sci USA 1984; 81: 5227–31
   PubMedGoogle Scholar
• Gallick G E, Kurzrock R, Kloetzer W S, Arlinghaus R B, Gutterman U. Expression of p21 ras in fresh primary and metastastic human colorectal tumors. Proc Natl Acad Sci USA 1985; 82: 1795–9
   PubMed Web of Science ®Google Scholar
• Viola M V, Fromowitz F, Oravez S, Deb S, Schlom J. Ras oncogene p21 expression is increased in premalignant lesions and high grade bladder carcinoma. J Exp Med 1985; 161: 1213–8
   PubMedGoogle Scholar
• Viola M V, Fromowitz F, Oravez S, et al. Expression of ras oncogene p21 in prostate cancer. N Engl J Med 1986; 314: 133–7
   PubMed Web of Science ®Google Scholar
• Lundy J, Crimson R, Mishriki Y, et al. Elevated ras oncogene expression correlates with lymph node metastases in breast cancer patients. J Clin Oncol 1986; 4: 1321–5
   PubMed Web of Science ®Google Scholar
• Kannan S, Balarm P, Pillai M R, Chandran C J, Nair M K. Immunohistochemical analysis of ras p21 expression in normal, pre‐malignant and malignant oral mucosa. Int J Cancer 1993; 55: 700–2
   PubMedGoogle Scholar
• Ramael M, Deblier I, Eerdekens C, Lemmens G, Jacobs W, van Marck E. Immunohistochemical staining of ras oncogene product in neoplastic and non‐neoplastic mesothelial tissues: Immunoreactivity for N‐ras and lack of immunohistochemical for H‐ras and K‐ras. J Pathol 1993; 169: 421–4
   PubMedGoogle Scholar
• Angel P, Karin M. The role of Jun and Fos and the AP‐1 complex in cell proliferation and transformation. Biochim Biophys Acta 1991; 1072: 129–57
   PubMed Web of Science ®Google Scholar
• Lee W, Mitchell P, Tjian R. Purified transcription factor AP‐1 interacts with TPA‐inducible enhancer elements. Cell 1987; 49: 741–52
   PubMed Web of Science ®Google Scholar
• Castro V M, Soderstrom M, Carlberg I, Widersten M, Platz A, Mannervik B. Differences among human tumor cell lines in the expression of glutathione transferases and other glutathione‐linked enzyms. Carcinogenesis 1990; 11: 1569–76
   PubMed Web of Science ®Google Scholar
• Okuda A, Sakai M, Muramatsu M. The structure of the rat glutatione S‐transferase P gene and related pseudogenes. J Biol Chem 1987; 262: 3858–63
   PubMed Web of Science ®Google Scholar